In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.
|Original language||English (US)|
|Journal||Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery|
|Issue number||1 Suppl|
|State||Published - Mar 2013|
ASJC Scopus subject areas